Nexium Study To Suppress Nausea During Chemotherapy
Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study will look at a drug called esomeprazole, the newest PPI, as a way to further
reduce the amount of nausea and vomiting seen in breast cancer patients receiving adriamycin
or epirubicin chemotherapy. Esomeprazole may help protect the gut lining from the stomach
acid and thus lessen the nausea and vomiting. If patients have less stomach sickness, they
may be able to enjoy their daily routines much more while they are getting chemotherapy.